BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34931335)

  • 1. Impact of severe mitral regurgitation on postoperative outcome after durable left-ventricular assist device implantation.
    Zubarevich A; Szczechowicz M; Arjomandi Rad A; Osswald A; Papathanasiou M; Luedike P; Koch A; Pizanis N; Kamler M; Schmack B; Ruhparwar A; Weymann A
    Artif Organs; 2022 May; 46(5):953-963. PubMed ID: 34931335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion.
    Sandoval E; Singh SK; Carillo JA; Baldwin ACW; Ono M; Anand J; Frazier OH; Mallidi HR
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):620-623. PubMed ID: 28962504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Baseline Mitral Regurgitation on Postoperative Outcomes After Left Ventricular Assist Device Implantation as Destination Therapy.
    Okoh A; Yanagida R; Schultheis M; Chaudari S; Fugar S; Nnaoma C; Chan O; Zucker MJ; Karanam R; Russo MJ; Camacho M
    Transplant Proc; 2019 Apr; 51(3):859-864. PubMed ID: 30979476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of mitral regurgitation in patients undergoing left ventricular assist device deployment: A systematic review and meta-analysis.
    Arjomandi Rad A; Zubarevich A; Shah V; Yilmaz O; Vardanyan R; Naruka V; Moorjani N; Ruhparwar A; Punjabi PP; Weymann A
    Artif Organs; 2023 Aug; 47(8):1250-1261. PubMed ID: 37086154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster analysis of preoperative echocardiographic findings and outcomes following left ventricular device implantation.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson K; Pagani FD
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1851-1860.e1. PubMed ID: 30739772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation.
    Pausch J; Bhadra O; Mersmann J; Conradi L; Sill B; Barten MJ; Reichenspurner H; Bernhardt AM
    J Cardiothorac Surg; 2022 Feb; 17(1):24. PubMed ID: 35216595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation.
    Kawabori M; Kurihara C; Conyer RT; Critsinelis AC; Sugiura T; Rosengart T; Morgan JA
    J Artif Organs; 2019 Jun; 22(2):91-97. PubMed ID: 30361785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis.
    Jain R; Truby LK; Topkara VK
    J Heart Lung Transplant; 2022 Nov; 41(11):1638-1645. PubMed ID: 35379546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension.
    Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation.
    Fujino T; Imamura T; Nitta D; Kim G; Smith B; Kalantari S; Nguyen A; Chung B; Narang N; Holzhauser L; Juricek C; Rodgers D; Song T; Ota T; Jeevanandam V; Burkhoff D; Sayer G; Uriel N
    Ann Thorac Surg; 2020 Sep; 110(3):918-924. PubMed ID: 32035052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist Device.
    Nakanishi K; Homma S; Han J; Takayama H; Colombo PC; Yuzefpolskaya M; Garan AR; Farr MA; Kurlansky P; Di Tullio MR; Naka Y; Takeda K
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29937432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.
    Hutter A; Bleiziffer S; Richter V; Opitz A; Hettich I; Mazzitelli D; Ruge H; Lange R
    Ann Thorac Surg; 2013 Jan; 95(1):77-84. PubMed ID: 23063197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in patients who underwent a concomitant tricuspid valve procedure during left ventricular assist device implantation.
    Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Loor G; Frazier OH; Morgan J
    J Card Surg; 2019 Dec; 34(12):1458-1464. PubMed ID: 31730728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    Hahn RT; Asch F; Weissman NJ; Grayburn P; Kar S; Lim S; Ben-Yehuda O; Shahim B; Chen S; Liu M; Redfors B; Medvedofsky D; Puri R; Kapadia S; Sannino A; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Sep; 76(11):1305-1314. PubMed ID: 32912445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
    Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival.
    Tanaka A; Onsager D; Song T; Cozadd D; Kim G; Sarswat N; Adatya S; Sayer G; Uriel N; Jeevanandam V; Ota T
    Ann Thorac Surg; 2017 Mar; 103(3):725-733. PubMed ID: 27659599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.